Breaking News Instant updates and real-time market news.

FORR

Forrester

$45.42 /

-0.545 (-1.19%)

04:55
03/03/21
03/03
04:55
03/03/21
04:55

Forrester management to meet virtually with Barrington

Virtual Meeting to be held on March 3 hosted by Barrington.

  • 03

    Mar

FORR Forrester
$45.42 /

-0.545 (-1.19%)

02/16/21 Barrington
Forrester price target raised to $50 from $44 at Barrington
08/03/20 Barrington
Forrester price target raised to $44 from $40 at Barrington
03/31/20 Barrington
Forrester upgraded to Outperform from Market Perform at Barrington

TODAY'S FREE FLY STORIES

Earnings
Osisko Gold reports Q1 preliminary revenue C$66.9M, one est. C$69.36M » 08:03
04/12/21
04/12
08:03
04/12/21
08:03
OR

Osisko Gold

$12.11 /

+0.065 (+0.54%)

Osisko received…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OR Osisko Gold
$12.11 /

+0.065 (+0.54%)

OR Osisko Gold
$12.11 /

+0.065 (+0.54%)

04/06/21 Scotiabank
Osisko Gold price target raised to C$28.50 from C$27.50 at Scotiabank
02/26/21 National Bank
Osisko Gold price target lowered to C$23 from C$23.50 at National Bank
02/25/21 BMO Capital
Osisko Gold price target lowered to C$20 from C$21 at BMO Capital
02/12/21 Scotiabank
Osisko Gold price target raised to C$27.50 from C$25 at Scotiabank
OR Osisko Gold
$12.11 /

+0.065 (+0.54%)

Hot Stocks
GT Biopharma reports interim results from GTB-3550 TriKE Phase I/II trial » 08:03
04/12/21
04/12
08:03
04/12/21
08:03
GTBP

GT Biopharma

$10.39 /

+1.79 (+20.81%)

GT Biopharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTBP GT Biopharma
$10.39 /

+1.79 (+20.81%)

GTBP GT Biopharma
$10.39 /

+1.79 (+20.81%)

03/17/21 Roth Capital
GT Biopharma initiated with a Buy at Roth Capital
  • 11
    Feb
Hot Stocks
AgroFresh Solutions appoints Clinton Lewis Jr. as CEO » 08:03
04/12/21
04/12
08:03
04/12/21
08:03
AGFS

AgroFresh Solutions

$2.15 /

-0.06 (-2.71%)

, PFE

Pfizer

$36.60 /

+0.64 (+1.78%)

, ZTS

Zoetis

$159.91 /

-0.12 (-0.07%)

AgroFresh Solutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGFS AgroFresh Solutions
$2.15 /

-0.06 (-2.71%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

ZTS Zoetis
$159.91 /

-0.12 (-0.07%)

AGFS AgroFresh Solutions
$2.15 /

-0.06 (-2.71%)

12/16/20 BMO Capital
AgroFresh Solutions initiated with a Market Perform at BMO Capital
PFE Pfizer
$36.60 /

+0.64 (+1.78%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
ZTS Zoetis
$159.91 /

-0.12 (-0.07%)

03/09/21 Stifel
Zoetis 'oversold,' among 'best long-term ideas,' says Stifel
03/08/21 Raymond James
Zoetis upgraded to Outperform from Market Perform at Raymond James
03/08/21 Raymond James
Zoetis upgraded to Outperform from Market Perform at Raymond James
03/08/21 BofA
Zoetis upgraded to Buy from Neutral at BofA
AGFS AgroFresh Solutions
$2.15 /

-0.06 (-2.71%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

ZTS Zoetis
$159.91 /

-0.12 (-0.07%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

Recommendations
Carlisle price target raised to $188 from $175 at Oppenheimer » 08:02
04/12/21
04/12
08:02
04/12/21
08:02
CSL

Carlisle

$171.68 /

+1.72 (+1.01%)

Oppenheimer analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSL Carlisle
$171.68 /

+1.72 (+1.01%)

CSL Carlisle
$171.68 /

+1.72 (+1.01%)

05:50 Today Longbow
Carlisle downgraded to Neutral from Buy at Longbow
03/25/21
Fly Intel: Top five analyst upgrades
03/25/21 Loop Capital
Carlisle upgraded to Buy from Hold at Loop Capital
01/26/21 Longbow
Carlisle price target raised to $160 from $150 at Longbow
CSL Carlisle
$171.68 /

+1.72 (+1.01%)

Initiation
SBA Communications initiated with a Buy at Jefferies » 08:01
04/12/21
04/12
08:01
04/12/21
08:01
SBAC

SBA Communications

$275.49 /

-4.15 (-1.48%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBAC SBA Communications
$275.49 /

-4.15 (-1.48%)

SBAC SBA Communications
$275.49 /

-4.15 (-1.48%)

03/25/21 KeyBanc
SBA Communications upgraded to Overweight from Sector Weight at KeyBanc
03/18/21 Wolfe Research
SBA Communications initiated with an Outperform at Wolfe Research
03/05/21 Raymond James
SBA Communications upgraded to Strong Buy from Outperform at Raymond James
03/05/21 Raymond James
SBA Communications upgraded to Strong Buy from Outperform at Raymond James
SBAC SBA Communications
$275.49 /

-4.15 (-1.48%)

SBAC SBA Communications
$275.49 /

-4.15 (-1.48%)

Initiation
Crown Castle initiated with a Buy at Jefferies » 08:00
04/12/21
04/12
08:00
04/12/21
08:00
CCI

Crown Castle

$175.26 /

-0.51 (-0.29%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCI Crown Castle
$175.26 /

-0.51 (-0.29%)

CCI Crown Castle
$175.26 /

-0.51 (-0.29%)

03/25/21 KeyBanc
Crown Castle upgraded to Overweight from Sector Weight at KeyBanc
03/19/21 Wolfe Research
Crown Castle initiated with a Peer Perform at Wolfe Research
01/14/21 Citi
Crown Castle upgraded to Buy from Neutral at Citi
01/11/21 BofA
BofA US 1 List changes
CCI Crown Castle
$175.26 /

-0.51 (-0.29%)

CCI Crown Castle
$175.26 /

-0.51 (-0.29%)

CCI Crown Castle
$175.26 /

-0.51 (-0.29%)

Initiation
American Tower initiated with a Buy at Jefferies » 08:00
04/12/21
04/12
08:00
04/12/21
08:00
AMT

American Tower

$239.06 /

-0.765 (-0.32%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMT American Tower
$239.06 /

-0.765 (-0.32%)

AMT American Tower
$239.06 /

-0.765 (-0.32%)

03/25/21 KeyBanc
American Tower upgraded to Overweight from Sector Weight at KeyBanc
03/18/21 Wolfe Research
American Tower initiated with an Outperform at Wolfe Research
03/08/21 RBC Capital
American Tower price target lowered to $250 from $275 at RBC Capital
02/26/21 Cowen
American Tower price target lowered to $324 from $334 at Cowen
AMT American Tower
$239.06 /

-0.765 (-0.32%)

Options
Gap call buyer realizes 60% same-day gains » 08:00
04/12/21
04/12
08:00
04/12/21
08:00
GPS

Gap

$32.43 /

+1.02 (+3.25%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPS Gap
$32.43 /

+1.02 (+3.25%)

GPS Gap
$32.43 /

+1.02 (+3.25%)

03/15/21 Wells Fargo
Gap price target raised to $40 from $32 at Wells Fargo
03/09/21 MKM Partners
Gap price target raised to $29 from $21 at MKM Partners
03/08/21 Barclays
Gap price target raised to $32 from $27 at Barclays
03/08/21 Deutsche Bank
Gap price target raised to $31 from $26 at Deutsche Bank
GPS Gap
$32.43 /

+1.02 (+3.25%)

GPS Gap
$32.43 /

+1.02 (+3.25%)

GPS Gap
$32.43 /

+1.02 (+3.25%)

GPS Gap
$32.43 /

+1.02 (+3.25%)

Hot Stocks
Unisys names Dwayne Allen as Chief Technology Officer » 07:56
04/12/21
04/12
07:56
04/12/21
07:56
UIS

Unisys

$24.11 /

-0.61 (-2.47%)

, MSFT

Microsoft

$255.73 /

+2.37 (+0.94%)

Unisys (UIS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UIS Unisys
$24.11 /

-0.61 (-2.47%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

UIS Unisys
$24.11 /

-0.61 (-2.47%)

12/07/20 Sidoti
Unisys reinstated with a Buy at Sidoti
MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

07:36 Today B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
07:29 Today Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
07:11 Today BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
04/09/21 BTIG
Okta upgraded to Buy from Neutral at BTIG
UIS Unisys
$24.11 /

-0.61 (-2.47%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

UIS Unisys
$24.11 /

-0.61 (-2.47%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

MSFT Microsoft
$255.73 /

+2.37 (+0.94%)

Initiation
Radius Global Infrastructure initiated with a Buy at Jefferies » 07:56
04/12/21
04/12
07:56
04/12/21
07:56
RADI

Radius Global Infrastructure

$15.47 /

+0.3 (+1.98%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RADI Radius Global Infrastructure
$15.47 /

+0.3 (+1.98%)

12/29/20 LightShed Partners
Radius Global Infrastructure initiated with a Buy at LightShed Partners
12/22/20
Fly Intel: Top five analyst initiations
12/22/20 Credit Suisse
Radius Global Infrastructure initiated with an Outperform at Credit Suisse
Conference/Events
Jefferies technology specialist to hold analyst/industry conference call » 07:55
04/12/21
04/12
07:55
04/12/21
07:55

Technology Specialist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
iTeos Therapeutics to hold a conference call » 07:55
04/12/21
04/12
07:55
04/12/21
07:55
ITOS

iTeos Therapeutics

$26.99 /

-3.12 (-10.36%)

Management discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

  • 24
    Jul
Conference/Events
Blueprint Medicines to host conference call » 07:55
04/12/21
04/12
07:55
04/12/21
07:55
BPMC

Blueprint Medicines

$94.14 /

+0.25 (+0.27%)

Management reviews new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
03/30/21 Credit Suisse
Blueprint Medicines initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Blueprint Medicines initiated with a Neutral at Credit Suisse
02/18/21 Barclays
Blueprint Medicines price target raised to $95 from $90 at Barclays
BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

Downgrade
Yaskawa Electric downgraded to Hold from Buy at Jefferies » 07:54
04/12/21
04/12
07:54
04/12/21
07:54
YASKY

Yaskawa Electric

$107.20 /

-0.89 (-0.82%)

Jefferies analyst Sho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YASKY Yaskawa Electric
$107.20 /

-0.89 (-0.82%)

01/04/21 Goldman Sachs
Yaskawa Electric upgraded to Buy from Neutral at Goldman Sachs
10/22/20 SMBC Nikko
Yaskawa Electric upgraded to Neutral from Underperform at SMBC Nikko
07/21/20 Daiwa
Yaskawa Electric downgraded to Neutral from Outperform at Daiwa
Hot Stocks
Alibaba affiliate Ant Group announces overhaul » 07:54
04/12/21
04/12
07:54
04/12/21
07:54
BABA

Alibaba

$223.35 /

-4.9 (-2.15%)

Alibaba affiliate Ant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

07:37 Today Raymond James
Alibaba price target lowered to $330 from $350 at Raymond James
06:41 Today Mizuho
Alibaba antitrust ruling 'removes overhang,' says Mizuho
06:37 Today Citi
Alibaba fine could help lift 'overhang' on shares, says Citi
06:36 Today KeyBanc
Alibaba price target lowered to $305 from $315 at KeyBanc
BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

BABA Alibaba
$223.35 /

-4.9 (-2.15%)

Upgrade
Jefferies upgrades Evelo Biosciences to Buy on increased microbiome momentum » 07:52
04/12/21
04/12
07:52
04/12/21
07:52
EVLO

Evelo Biosciences

$10.03 /

+0.005 (+0.05%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

04:50 Today Jefferies
Evelo Biosciences upgraded to Buy from Hold at Jefferies
03/12/21 Chardan
Evelo Biosciences price target raised to $15 from $10 at Chardan
01/25/21 JMP Securities
Evelo Biosciences price target raised to $36 from $27 at JMP Securities
12/30/20 JMP Securities
Evelo shares undervalued into atopic dermatitis data, says JMP Securities
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

  • 29
    Jan
  • 25
    Jun
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

Initiation
Duckhorn Portfolio initiated with a Buy at Jefferies » 07:48
04/12/21
04/12
07:48
04/12/21
07:48
NAPA

Duckhorn Portfolio

$18.89 /

+0.785 (+4.34%)

Jefferies analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAPA Duckhorn Portfolio
$18.89 /

+0.785 (+4.34%)

07:19 Today JPMorgan
Duckhorn Portfolio initiated with an Overweight at JPMorgan
06:48 Today Citi
Duckhorn Portfolio initiated with a Buy at Citi
06:44 Today Evercore ISI
Duckhorn Portfolio initiated with an Outperform at Evercore ISI
06:24 Today Credit Suisse
Duckhorn Portfolio initiated with an Outperform at Credit Suisse
  • 18
    Mar
NAPA Duckhorn Portfolio
$18.89 /

+0.785 (+4.34%)

NAPA Duckhorn Portfolio
$18.89 /

+0.785 (+4.34%)

Hot Stocks
Jazz Pharmaceuticals: FDA grants Priority Review of sNDA for Xywav » 07:48
04/12/21
04/12
07:48
04/12/21
07:48
JAZZ

Jazz Pharmaceuticals

$161.34 /

+0.43 (+0.27%)

Jazz Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

04/06/21 RBC Capital
Jazz Pharmaceuticals transferred with an Outperform at RBC Capital
04/01/21 Morgan Stanley
Jazz Pharmaceuticals price target raised to $176 from $162 at Morgan Stanley
03/01/21 UBS
Jazz Pharmaceuticals price target raised to $228 from $174 at UBS
02/24/21 Cowen
Jazz Pharmaceuticals price target raised to $200 from $190 at Cowen
JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

JAZZ Jazz Pharmaceuticals
$161.34 /

+0.43 (+0.27%)

Hot Stocks
Beyond Meat announces product distribution expansion with European retailers » 07:48
04/12/21
04/12
07:48
04/12/21
07:48
BYND

Beyond Meat

$130.24 /

-4.45 (-3.30%)

Beyond Meat announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

04/07/21 Piper Sandler
Piper Sandler survey shows more teens open to plant-based meat
04/05/21 JPMorgan
BellRing, Hostess among JPMorgan's 'Own Now' names in food
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Stephens
Stephens starts Beyond Meat at buy with alternative protein 'going mainstream'
BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

BYND Beyond Meat
$130.24 /

-4.45 (-3.30%)

Earnings
InMode sees Q1 adjusted EPS 65c-67c, consensus 46c » 07:46
04/12/21
04/12
07:46
04/12/21
07:46
INMD

InMode

$80.64 /

-0.19 (-0.24%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$80.64 /

-0.19 (-0.24%)

INMD InMode
$80.64 /

-0.19 (-0.24%)

02/11/21 Baird
InMode price target raised to $84 from $58 at Baird
02/11/21 Canaccord
InMode price target raised to $80 from $69 at Canaccord
02/11/21 UBS
InMode price target raised to $84 from $64 at UBS
10/21/20 Canaccord
InMode price target raised to $51 from $42 at Canaccord
INMD InMode
$80.64 /

-0.19 (-0.24%)

INMD InMode
$80.64 /

-0.19 (-0.24%)

Hot Stocks
Centerra Gold to list common shares on NYSE » 07:45
04/12/21
04/12
07:45
04/12/21
07:45
CGAU

Centerra Gold

/

+

Centerra Gold is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
PROG Holdings price target lowered to $58 from $65 at Truist » 07:45
04/12/21
04/12
07:45
04/12/21
07:45
PRG

PROG Holdings

$43.93 /

+0.5 (+1.15%)

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

02/24/21 Stephens
Aaron's peers also potentially received California inquiry, says Stephens
12/22/20 Raymond James
Rent-A-Center price target raised to $45 from $38 at Raymond James
12/22/20 Stephens
Rent-A-Center price target raised to $52 from $45 at Stephens
12/14/20 Berenberg
Aaron's initiated with a Buy at Berenberg
PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

PRG PROG Holdings
$43.93 /

+0.5 (+1.15%)

Hot Stocks
Cytokinetics announces preclinical data for CK-3773274 » 07:45
04/12/21
04/12
07:45
04/12/21
07:45
CYTK

Cytokinetics

$24.17 /

+0.01 (+0.04%)

Cytokinetics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

  • 17
    Jul
CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

Initiation
Vine Energy initiated with an Overweight at Morgan Stanley » 07:44
04/12/21
04/12
07:44
04/12/21
07:44
VEI

Vine Energy

$12.11 /

+0.11 (+0.92%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VEI Vine Energy
$12.11 /

+0.11 (+0.92%)

06:50 Today Citi
Vine Energy initiated with a Buy at Citi
06:22 Today Barclays
Vine Energy initiated with an Equal Weight at Barclays
06:17 Today RBC Capital
Vine Energy initiated with an Outperform at RBC Capital
06:16 Today BofA
Vine Energy initiated with a Buy at BofA
  • 18
    Mar
VEI Vine Energy
$12.11 /

+0.11 (+0.92%)

Hot Stocks
OpGen announces results from webinar on bacterial pneumonia co-infections » 07:42
04/12/21
04/12
07:42
04/12/21
07:42
OPGN

OpGen

$2.68 /

-0.045 (-1.65%)

OpGen announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$2.68 /

-0.045 (-1.65%)

OPGN OpGen
$2.68 /

-0.045 (-1.65%)

03/02/21 Alliance Global Partners
Alliance Global raises OpGen price target to $7, sees 'eventful 2021'
11/13/20 Alliance Global Partners
OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners
06/09/20 Alliance Global Partners
Alliance Global Partners sees OpGen preliminary data as positive
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
OPGN OpGen
$2.68 /

-0.045 (-1.65%)

OPGN OpGen
$2.68 /

-0.045 (-1.65%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.